lysergol has been researched along with 9,10-dihydrolysergol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuller, RW; Horng, JS; Mason, NR; Merritt, L; Paschal, JW; Snoddy, HD; Ward, JS | 1 |
| Eich, E; Pertz, H | 1 |
| Eich, E; Milhahn, H; Pertz, HH | 1 |
3 other study(ies) available for lysergol and 9,10-dihydrolysergol
| Article | Year |
|---|---|
Ergolines as selective 5-HT1 agonists.
Topics: Animals; Apomorphine; Brain; Chemical Phenomena; Chemistry; Corticosterone; Drug Interactions; Ergolines; Fenclonine; Hydroxyindoleacetic Acid; Rats; Receptors, Serotonin; Serotonin; Structure-Activity Relationship | 1988 |
O-acylated lysergol and dihydrolysergol-I derivatives as competitive antagonists of 5-HT at 5-HT2 receptors of rat tail artery. Allosteric modulation instead of pseudoirreversible inhibition.
Topics: Animals; Binding, Competitive; Ergolines; In Vitro Techniques; Lysergic Acid; Male; Methysergide; Muscle Contraction; Muscle, Smooth, Vascular; Phenylephrine; Rats; Rats, Inbred Strains; Receptors, Adrenergic, alpha; Regional Blood Flow; Serotonin Antagonists; Tail | 1992 |
Cycloalkanecarboxylic esters derived from lysergol, dihydrolysergol-I, and elymoclavine as partial agonists and antagonists at rat 5-HT2A receptors: pharmacological evidence that the indolo[4,3-fg]quinoline system of the ergolines is responsible for high
Topics: Animals; Aorta, Thoracic; Arteries; Ergolines; Female; Guinea Pigs; Iliac Artery; In Vitro Techniques; Lysergic Acid; Male; Muscle Contraction; Muscle, Smooth, Vascular; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT1B; Receptor, Serotonin, 5-HT2A; Receptors, Adrenergic, alpha-1; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Tail | 1999 |